microdosing tirzepatide for weight loss pros and cons of GLP-1 agonists—using doses below FDA-approved levels Tirzepatide Microdose (Injections) – Immortals

15: Villani, R.G., Gannon, J., Self, M

Metformin is a first-line drug for treating type 2 diabetes 14

This fundamental difference in metabolism means they do not compete for the same enzymatic pathways, minimising the risk of one medication affecting the blood levels of the other

When every sponsor wants to start GLP-1 studies within the same six-month window, no one has a staffing advantageunless they planned months ahead

Its not going to be as straightforward as some of the fraud schemes that we often see, but I dont think its outside of the realm of possibility. There are also conversations about how detrimental it could be for Medicare beneficiaries to lose access to GLP-1 medications designed to improve their health if the program doesnt continue past December 2027